You are here

  • Home
  • Archive
  • Volume 71, Issue 7
  • A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mease P, Strand V, Shalamberidze L, et al
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
Annals of the Rheumatic Diseases 2012;71:1183-1189.